Allergan, Inc., insists that it isn’t asking for much in the suit it recently filed against the government—just the right to talk about unapproved uses of its medications.
The Food and Drug Administration already allows Allergan to recommend its antispasm treatment, Botox, for crossed eyes, eyelid spasms, and involuntary contractions of the neck muscles. But the California-based company wants to tell doctors about other “off-label” uses of Botox that haven’t been cleared by the FDA yet. (Allergan also makes the antiwrinkling treatment Botox Cosmetic.)
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
